Comparison of serum adipocyte fatty acid binding protein (A-FABP) levels in prediabetic patients and healthy individuals
Journal of Endocrinology · 01.05.2026 · 269 (2)
DOI: 10.1530/joe-25-0001 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Endocrinology, online erschienen am 24.04.2026. Verfasst von Aydan Taka Küçük und 3 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine, Tepecik Training and Research Hospital, Konak, Turkey. Hauptthemen laut MEDLINE: Fatty Acid-Binding Proteins, Prediabetic State. Die Arbeit nennt 31 Literaturangaben.
Abstract (Originalsprache)
Prediabetes, a condition defined by the World Health Organization (WHO), has become a significant global health issue affecting a substantial portion of the world’s population. This study aims to investigate the levels of adipocyte fatty acid-binding protein-4 (a-FABP or FABP-4), a biomarker found in individuals with prediabetes. FABP-4 is a protein released by both adipocytes and macrophages and plays a crucial role in influencing insulin resistance and lipid metabolism. The focus of this study is to evaluate FABP-4 levels in individuals with prediabetes and its correlation with metabolic parameters and CRP levels. The study was conducted on 90 participants, including individuals diagnosed with prediabetes (n = 44) and a healthy control (n = 44) group. The findings reveal that FABP-4 levels are significantly elevated in individuals with prediabetes. Furthermore, positive correlations were observed between FABP-4 levels and fasting and postprandial blood glucose, HbA1c, and C-reactive protein (CRP). Regression analysis indicates that FABP-4 is independently associated with prediabetes and, when considered alongside the triglyceride-to-high-density lipoprotein (HDL) ratio, is associated with prediabetes. This study underscores the association between FABP-4 and prediabetes, highlighting its potential role in fundamental processes such as insulin resistance, lipolysis, and inflammation. Additionally, it suggests that the triglyceride/HDL ratio is significantly associated with prediabetes. In conclusion, FABP-4 and the triglyceride/HDL ratio have the potential to be utilized as biomarkers in the assessment of prediabetes, contributing to the development of new treatment targets in this context.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Internal Medicine, Tepecik Training and Research Hospital, Konak, Turkey.
- Medical Biochemistry, Tepecik Training and Research Hospital, Konak, Turkey.
- Endocrinology, Tepecik Training and Research Hospital, Ankara, Turkey.
Zitieren
APA
Taka Küçük, A., Ulaş, E., Akşit, M., & Yılmaz Yaşar, H. (2026). Comparison of serum adipocyte fatty acid binding protein (A-FABP) levels in prediabetic patients and healthy individuals. Journal of Endocrinology, 269(2). https://doi.org/10.1530/joe-25-0001
Vancouver
Taka Küçük A, Ulaş E, Akşit M, Yılmaz Yaşar H. Comparison of serum adipocyte fatty acid binding protein (A-FABP) levels in prediabetic patients and healthy individuals. Journal of Endocrinology. 2026;269(2). doi:10.1530/joe-25-0001
BibTeX
@article{TakaKk2026,
author = {Taka Küçük, Aydan and Ulaş, Ezgi and Akşit, Murat and Yılmaz Yaşar, Hamiyet},
title = {Comparison of serum adipocyte fatty acid binding protein (A-FABP) levels in prediabetic patients and healthy individuals},
journal = {Journal of Endocrinology},
year = {2026},
volume = {269},
number = {2},
doi = {10.1530/joe-25-0001}
}
EUVIMED